Streetbeat News

Stock Prices

CLOV

Clover Health Investments shares are trading higher following the purchase of shares by director Vivek Garipalli.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:10 pm

YMAB

Y-mAbs Therapeutics shares are trading, potentially rebounding after a decline earlier in the week due to weak earnings and guidance.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:06 pm

GILD

The FDA has approved Gilead Sciences' new drug, Livdelzi, for the treatment of Primary Biliary Cholangitis, according to Reuters citing the company's website.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:03 pm

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) announced the acquisition of one million common shares of Bitfarms, increasing its ownership to 18.90%. Additionally, Riot reported a significant increase in Bitcoin production and hash rate for July 2024, and announced the acquisition of Block Mining, which will boost its self-mining capacity. Despite these positive developments, Riot's stock is down 2.68% to $7.63.

Portfolio Pulse from Dylan Berman

August 14, 2024 | 5:03 pm

LYFT

Over the past three months, 28 analysts have provided ratings for Lyft (NASDAQ:LYFT), with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has decreased by 12.61% to $16.43. Recent analyst actions predominantly involve lowering price targets and ratings, reflecting cautious sentiment towards Lyft's stock. Despite this, Lyft has shown positive financial performance with significant revenue growth, strong net margin, ROE, and ROA, and balanced debt management.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:01 pm

TJX

12 analysts have provided ratings for TJX Companies (NYSE:TJX) over the past quarter, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 4.15% to $119.25. Analysts have raised their price targets, reflecting positive market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:01 pm

AMAT

IYJ

JEPQ

NU

The CNBC Halftime Report highlighted final trades including Applied Materials, Nu Holdings, iShares U.S. Industrials ETF, and JPMorgan Nasdaq Equity Premium Income ETF.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 5:01 pm

IP

Over the past three months, 11 analysts have shared their insights on International Paper (NYSE:IP), with a mix of bullish and indifferent opinions. Analysts have set a 12-month average price target of $50.34, up 13.43% from the previous target. Key analysts have raised their price targets, reflecting positive sentiment. Financially, International Paper shows strong revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:00 pm

ABBV

Deep-pocketed investors are showing a bullish sentiment towards AbbVie (NYSE:ABBV) with significant options activity. Benzinga's options scanner highlighted 9 extraordinary options activities, with a majority being calls. Analysts have set an average price target of $209.4, with ratings ranging from Overweight to Buy.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:00 pm

PRVA

Analysts have mixed views on Privia Health Group (NASDAQ: PRVA) with recent ratings showing a shift towards somewhat bullish sentiments. The average 12-month price target has decreased by 7.52% to $22.5. Key analysts have maintained or lowered their ratings and price targets, reflecting dynamic market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 5:00 pm